Literature DB >> 17634054

Determinants of sexual satisfaction in men with prostate cancer.

Christian J Nelson1, Judy M Choi, John P Mulhall, Andrew J Roth.   

Abstract

OBJECTIVE: There is a growing debate about the important determinants of sexual satisfaction in men. Some authors argue that men's sexual satisfaction correlates with physical functioning variables such as erection quality and ejaculatory time. Other authors have suggested that the limited literature indicates that men's sexual satisfaction is related to psychosocial variables such as relationship satisfaction, depression, or anxiety. This study is the first to our knowledge to explore this question in men with prostate cancer.
MATERIALS AND METHODS: This archival, cross-sectional research analyzed quality-of-life, depression, and anxiety data on 352 men with early- and late-stage prostate cancer. Questions from the Functional Assessment of Cancer Therapy Scale-Prostate Cancer Version were used to assess sexual satisfaction, erectile function, and relationship closeness. The Hospital Anxiety and Depression Scale was used to assess anxiety and depression.
RESULTS: In general, the subjects reported low sexual satisfaction with a mean score of 2.3 on a 5-point Likert scale (1-5). In the correlational analyses, arthritis, brachytherapy, and depression/anxiety were all negatively associated with sexual satisfaction, while erectile function and relationship closeness were positively associated with sexual satisfaction (P < 0.05). In the subsequent multivariate analysis, erectile function (P < 0.01), relationship closeness (P < 0.05), and depression/anxiety (P < 0.05) remained significant predictors of sexual satisfaction. In this model, erectile functioning produced the largest effect (beta = 0.57) as compared to relationship closeness and depression/anxiety (beta values approximately 0.11).
CONCLUSION: In this sample of men with prostate cancer, both physical and psychosocial variables were found to be important determinants of sexual satisfaction. Erectile function appears to have the strongest association with sexual satisfaction; however, variables such as relationship quality, depression, and anxiety are also clearly related to a satisfying sex life in this sample.

Entities:  

Mesh:

Year:  2007        PMID: 17634054     DOI: 10.1111/j.1743-6109.2007.00547.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  15 in total

1.  Prediction of erectile function following treatment for prostate cancer.

Authors:  Mehrdad Alemozaffar; Meredith M Regan; Matthew R Cooperberg; John T Wei; Jeff M Michalski; Howard M Sandler; Larry Hembroff; Natalia Sadetsky; Christopher S Saigal; Mark S Litwin; Eric Klein; Adam S Kibel; Daniel A Hamstra; Louis L Pisters; Deborah A Kuban; Irving D Kaplan; David P Wood; Jay Ciezki; Rodney L Dunn; Peter R Carroll; Martin G Sanda
Journal:  JAMA       Date:  2011-09-21       Impact factor: 56.272

Review 2.  Nerve growth factor modulation of the cavernous nerve response to injury.

Authors:  Anthony J Bella; Guiting Lin; Ching-Shwun Lin; Duane R Hickling; Christopher Morash; Tom F Lue
Journal:  J Sex Med       Date:  2009-03       Impact factor: 3.802

3.  Erectile dysfunction after prostate three-dimensional conformal radiation therapy. Correlation with the dose to the penile bulb.

Authors:  A Magli; M Giangreco; M Crespi; A Negri; T Ceschia; G De Giorgi; F Titone; G Parisi; S Fongione
Journal:  Strahlenther Onkol       Date:  2012-09-29       Impact factor: 3.621

4.  [Urgency after successful treatment of prostate cancer. Prospective study on the influence of treatment modality, morbidity, and epidemiological factors on the quality of life].

Authors:  R Kirschner-Hermanns; T Klementz; A Haselhuhn; G Jakse; A Heidenreich; B Brehmer
Journal:  Urologe A       Date:  2011-11       Impact factor: 0.639

5.  [Sexuality after radical prostatectomy: Evaluation of erectile function and patient counseling regarding their sex life].

Authors:  M L Schmidtke; A Dinkel; J E Gschwend; K Herkommer
Journal:  Urologe A       Date:  2015-05       Impact factor: 0.639

Review 6.  Testosterone therapy and prostate carcinoma.

Authors:  Ernani Luis Rhoden; Márcio Augusto Averbeck
Journal:  Curr Urol Rep       Date:  2009-11       Impact factor: 3.092

7.  Back to baseline: erectile function recovery after radical prostatectomy from the patients' perspective.

Authors:  Christian J Nelson; Peter T Scardino; James A Eastham; John P Mulhall
Journal:  J Sex Med       Date:  2013-04-03       Impact factor: 3.802

8.  Millon Behavioral Medicine Diagnostic (MBMD) Predicts Health-Related Quality of Life (HrQoL) over time among men treated for localized prostate cancer.

Authors:  Dean G Cruess; Catherine Benedict; Emily G Lattie; Ivan Molton; Dave Kinsinger; Bruce Kava; Murugesan Manoharan; Mark Soloway; Frank J Penedo
Journal:  J Pers Assess       Date:  2012-05-09

Review 9.  Intermittent versus continuous androgen deprivation therapy for advanced prostate cancer.

Authors:  Marlon Perera; Matthew J Roberts; Laurence Klotz; Celestia S Higano; Nathan Papa; Shomik Sengupta; Damien Bolton; Nathan Lawrentschuk
Journal:  Nat Rev Urol       Date:  2020-06-30       Impact factor: 14.432

10.  Couple Counseling and Pelvic Floor Muscle Training for Men Operated for Prostate Cancer and for Their Female Partners: Results From the Randomized ProCan Trial.

Authors:  Randi V Karlsen; Pernille E Bidstrup; Annamaria Giraldi; Helle Hvarness; Per Bagi; Susanne Vahr Lauridsen; Vanna Albieri; Marie Frederiksen; Eva Krause; Ulla Due; Christoffer Johansen
Journal:  Sex Med       Date:  2021-06-03       Impact factor: 2.491

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.